Sanborn, R., Boulmay, B., Li, R., Spieler, B., Happel, K., Paustian, C., . . . Hilton, T. (2015). Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC. J Immunother Cancer.
Citação norma ChicagoSanborn, Rachel, et al. "Preliminary Analysis of Immune Responses in Patients Enrolled in a Phase II Trial of Cyclophosphamide With Allogenic Dribble Vaccine Alone (DPV-001) or With GM-CSF or Imiquimod for Adjuvant Treatment of Stage IIIa or IIIb NSCLC." J Immunother Cancer 2015.
MLA CitationSanborn, Rachel, et al. "Preliminary Analysis of Immune Responses in Patients Enrolled in a Phase II Trial of Cyclophosphamide With Allogenic Dribble Vaccine Alone (DPV-001) or With GM-CSF or Imiquimod for Adjuvant Treatment of Stage IIIa or IIIb NSCLC." J Immunother Cancer 2015.